Autonomic aspects of arrhythmogenesis: The enduring and the new

Current Opinion in Cardiology

Volumn 19, Issue 1, 2004, Pages 2-11

  Verrier, Richard L ^a   Antzelevitch, Charles ^b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASONIC MEDICAL RESEARCH LABORATORY   (United States)

Author keywords

Baroreceptor reflexes; Behavioral stress; Brugada syndrome; Cardiac arrhythmias; Electrical remodeling; Intrinsic cardiac innervation; LQTS

Indexed keywords

ACTION POTENTIAL; AGING; ARRHYTHMOGENESIS; BRUGADA SYNDROME; CARDIOMYOPATHY; CORONARY ARTERY BLOOD FLOW; CORONARY ARTERY DISEASE; DEFIBRILLATOR; DIABETIC NEUROPATHY; DISEASE COURSE; DISEASE SEVERITY; ELECTRIC ACTIVITY; ELECTROCARDIOGRAM; ELECTROLYTE DISTURBANCE; HEART INFARCTION; HEART INNERVATION; HEART RATE VARIABILITY; HEART REPOLARIZATION; HEART SURGERY; HEART VENTRICLE EXTRASYSTOLE; HIGH RISK PATIENT; HUMAN; ISCHEMIC HEART DISEASE; LONG QT SYNDROME; MORBIDITY; NUCLEOTIDE SEQUENCE; PRESSORECEPTOR; PRIORITY JOURNAL; QT INTERVAL; REVIEW; SINUS RHYTHM; STATISTICAL SIGNIFICANCE; T WAVE; VAGUS NERVE; ADRENERGIC SYSTEM; AUTONOMIC NERVOUS SYSTEM; CHOLINERGIC SYSTEM; ELECTROCARDIOGRAPHY; HEART; HEART ARRHYTHMIA; HEART RATE; INNERVATION; PATHOPHYSIOLOGY; PHYSIOLOGY; PSYCHOLOGICAL ASPECT;

ARRHYTHMIA; AUTONOMIC NERVOUS SYSTEM; ELECTROCARDIOGRAPHY; HEART; HEART RATE; HUMANS; PARASYMPATHETIC NERVOUS SYSTEM; PRESSORECEPTORS; SYMPATHETIC NERVOUS SYSTEM;

EID: 2542462553     PISSN: 02684705     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001573-200401000-00003     Document Type: Review

References (99)

1. Lown B, Verrier RL. Neural activity and ventricular fibrillation. N Engl J Med 1976; 294:1165-1170.
2. Lathrop DA, Spooner PM. On the neural connection. J Cardiovasc Electrophysiol 2001; 12:841-844.
3. Lombardi F. Clinical implications of present physiological understanding of HRV components. Card Electrophysiol Rev 2002; 6:245-249. Excellent recent review on HRV.
4. Folino AF, Buja G, Bauce B, et al. Heart rate variability in arrhythmogenic right ventricular cardiomyopathy: correlation with clinical and prognostic features. PACE 2002; 25:1285-1292. Reduction in vagal activity correlates with ventricular arrhythmias and extent of disease in patients with right ventricular dysplasia.
5. Lucini D, Mela GS, Malliani A, et al. Impairment in cardiac autonomic regulation preceding arterial hypertension in humans: insights from spectral analysis of beat-by-beat cardiovascular variability. Circulation 2002; 106:2673-2679. Excess cardiovascular risk attributable to autonomic dysregulation was found in individuals with blood pressure at upper range of normal. This finding underscores a mechanistic role of autonomic dysregulation in risk of cardiovascular events.
6. Davos CH, Davlouros PA, Wensel R, et al. Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation 2002; 106:169-175.
7. Bonnemeier H, Richardt G, Potratz J, et al. Circadian profile of cardiac autonomic nervous modulation in healthy subjects: differing effects of aging and gender on heart rate variability. J Cardiovasc Electrophysiol 2003; 14:791-799.
8. Myslivecek PR, Brown CA, Wolfe LA. Effects of physical conditioning on cardiac autonomic function in healthy middle-aged women. Can J Appl Physiol 2002; 27:1-18.
9. Carnethon MR, Golden SH, Folsom AR, et al. Prospective investigation of autonomic nervous system function and the development of type 2 diabetes: the Atherosclerosis Risk in Communities Study, 1987-1998. Circulation 2003; 107:2190-2195. HRV analysis can be used to screen community populations to identify individuals at risk for developing type 2 diabetes.
10. Lindmark S, Wiklund U, Bjerle P, et al. Does the autonomic nervous system play a role in the development of insulin resistance? A study on heart rate variability in first-degree relatives of Type 2 diabetes patients and control subjects. Diabet Med 2003; 20:399-405. Attenuated vagus nerve activity is characteristic of early stages of insulin resistance.
11. Liao D, Carnethon M, Evans GW, et al. Lower heart rate variability is associated with the development of coronary heart disease in individuals with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes 2002; 51:3524-3531. Impairment in autonomic activity contributes to risk of coronary artery disease in diabetic patients.
12. Momiyama Y, Suzuki Y, Ohtomo M, et al. Cardiac autonomic nervous dysfunction in diabetic patients with a mitochondrial DNA mutation: assessment by heart rate variability. Diabetes Care 2002; 25:2308-2313. Autonomic balance is more severely impaired in diabetic patients with mitochondrial DNA mutation.
13. Manzella D, Carbonella M, Ragno E, et al. Relationship between autonomic cardiac activity, beta-cell function, anthropometrics and metabolic indices in type II diabetics. Clin Endocrinol (Oxf) 2002; 57:259-264. Preserved C-peptide secretion is characteristic of patients with type II diabetes with well-balanced autonomic activity.
14. Hoeldtke RD, Bryner KD, McNeill DR, et al. Nitrosative stress, uric acid, and peripheral nerve function in early type 1 diabetes. Diabetes 2002; 51:2817-2825. Preserved C-peptide secretion is characteristic of patients with type II diabetes with well-balanced autonomic activity.
15. Kara T, Nykodym J, Somers VK. Heart rate variability: back to the beginning. J Cardiovasc Electrophysiol 2003; 14:800-802. Editorial on Bonnemeier et al. [7] with detailed discussion of HRV.
16. Routledge HC, Chowdhary S, Townend JN. Heart rate variability: a therapeutic target? J Clin Pharm Ther 2002; 27:85-92. Augmentation of cardiac vagal tone is suggested as a treatment strategy in the context of β-adrenergic receptor blockade, angiotensin-converting enzyme and aldosterone inhibition, scopolamine therapy, and exercise conditioning.
17. Tanasescu M, Leitzmann MF, Rimm EB, et al. Physical activity in relation to cardiovascular disease and total mortality among men with type 2 diabetes. Circulation 2003; 107:2435-2439.
18. Carnethon MR, Liao D, Evans GW, et al. Does the cardiac autonomic response to postural change predict incident coronary heart disease and mortality? The Atherosclerosis Risk in Communities Study. Am J Epidemiol 2002; 155:48-56.
19. Grimm W, Herzum I, Muller HH, et al. Value of heart rate variability to predict ventricular arrhythmias in recipients of prophylactic defibrillators with idiopathic dilated cardiomyopathy. PACE 2003; 26:411-415. Negative finding of the utility of HRV to predict appropriate ICD shocks in patients with idiopathic dilated cardiomyopathy. The investigators conclude that HRV is not a suitable tool to guide ICD implantation.
20. Gold DR, Litonjua A, Schwartz J, et al. Ambient pollution and heart rate variability. Circulation 2000; 101:1267-1273.
21. Magari SR, Schwartz J, Williams PL, et al. The association between personal measurements of environmental exposure to particulates and heart rate variability. Epidemiology 2002; 13:305-310. Air particulate pollution affects cardiac autonomic function as indicated by HRV analyses.
22. Billman GE, Schwartz PJ, Stone HL. Baroreceptor reflex control of heart rate: a predictor of sudden cardiac death. Circulation 1982; 66:874-880.
23. Levy MN, Blattberg B.Effect of vagal stimulation on the overflow of norepinephrine into the coronary sinus during cardiac sympathetic nerve stimulation in the dog. Circ Res 1976; 38:81-84.
24. Kolman BS, Verrier RL, Lown B. The effect of vagus nerve stimulation upon vulnerability of the canine ventricle: role of sympathetic-parasympathetic interactions. Circulation 1975; 52:578-585.
25. La Rovere MT, Bigger JT Jr, Marcus FI, et al. Baroreflex sensitivity and heart-rate variability in prediction of total cardiac mortality after myocardial infarction. ATRAMI (Autonomic Tone and Reflexes After Myocardial Infarction) Investigators. Lancet 1998; 351:478-484.
26. Lin LY, Lai LP, Lin JL, et al. Tight mechanism correlation between heart rate turbulence and baroreflex sensitivity: sequential autonomic blockade analysis. J Cardiovasc Electrophysiol 2002; 13:427-431.
27. Schmidt G, Malik M, Barthel P, et al. Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction. Lancet 1999; 353:1390-1396.
28. Ghuran A, Reid F, La Rovere MT, et al. Heart rate turbulence-based predictors of fatal and nonfatal cardiac arrest (The Autonomic Tone and Reflexes After Myocardial Infarction Substudy). Am J Cardiol 2002; 89:184-190.
29. Grimm W, Schmidt G, Maisch B, et al. Prognostic significance of heart rate turbulence following ventricular premature beats in patients with idiopathic dilated cardiomyopathy. J Cardiovasc Electrophysiol 2003; 14:819-824. HRT is a significant predictor of transplant-free survival in idiopathic dilated cardiomyopathy patients but does not stratify risk for ventricular arrhythmia.
30. Guzik P, Schmidt G. A phenomenon of heart-rate turbulence, its evaluation, and prognostic value. Card Electrophysiol Rev 2002; 6:256-261. Important, thorough review of HRT.
31. Wichterle D, Melenovsky V, Malik M. Mechanisms involved in heart rate turbulence. Card Electrophysiol Rev 2002; 6:262-266. Discussion of autonomic basis for HRT.
32. Bonnemeier H, Wiegand UK, Friedlbinder J, et al. Reflex cardiac activity in ischemia and reperfusion: heart rate turbulence in patients undergoing direct percutaneous coronary intervention for acute myocardial infarction. Circulation 2003; 108:958-964.
33. Watanabe MA, Marine JE, Sheldon R, et al. Effects of ventricular premature stimulus coupling interval on blood pressure and heart rate turbulence. Circulation 2002; 106:325-330. Clinical study indicating the suitability of induction of premature beats in the electrophysiology laboratory to measure HRT.
34. Armour JA. Intrinsic cardiac neurons. J Cardiovasc Electrophysiol 1991; 2:331-341.
35. Randall WC, Ardell JL. Selective parasympathectomy of automatic and conductile tissues of the canine heart. Am J Physiol 1985; 248:H61-H68.
36. Chiou CW, Eble JN, Zipes DP. Efferent vagal innervation of the canine atria and sinus and atrioventricular nodes: the third fat pad. Circulation 1998; 95:2573-2584.
37. Verrier RL, Zhao SX. The enigmatic cardiac fat pads: critical but underappreciated neural regulatory sites. J Cardiovasc Electrophysiol 2002; 13:902-903. Terse review of intrinsic neural regulation by the cardiac fat pads.
38. Armour JA. Myocardial ischaemia and the cardiac nervous system. Cardiovasc Res 1999; 41:41-54.
39. Stevens MJ, Raffel DM, Allman KC, et al. Cardiac sympathetic dysinnervation in diabetes: implications for enhanced cardiovascular risk. Circulation 1998; 98:961-968.
40. Randall WC, Wurster RD, Duff M, et al. Surgical interruption of postganglionic innervation of the sinoatrial nodal region. J Thorac Cardiovasc Surg 1991; 101:66-74.
41. Nakajima K, Furukawa Y, Kurogouchi F, et al. Autonomic control of the location and rate of the cardiac pacemaker in the sinoatrial fat pad of parasympathetically denervated dog hearts. J Cardiovasc Electrophysiol 2002; 13:896-901.
42. Quan KJ, Lee JH, Van Hare GF, et al. Identification and characterization of atrioventricular parasympathetic innervation in humans. J Cardiovasc Electrophysiol 2002; 13:735-739. The authors identified in humans an epicardial fat pad from which parasympathetic nerve fibers electrically innervate the atrioventricular but not the sinoatrial node.
43. Jayachandran JV, Sih HJ, Winkle W, et al. Atrial fibrillation produced by prolonged rapid atrial pacing is associated with heterogeneous changes in atrial sympathetic innervation. Circulation 2000; 101:1185-1191.
44. Olgin JE, Sih HJ, Hanish S, et al. Heterogeneous atrial denervation creates substrate for sustained atrial fibrillation. Circulation 1998; 98:2608-2614.
45. Chang CM, Wu TJ, Zhou S, et al. Nerve sprouting and sympathetic hyperinnervation in a canine model of atrial fibrillation produced by prolonged right atrial pacing. Circulation 2001; 103:22-25.
46. Chen PS, Chen LS, Cao JM, et al. Sympathetic nerve sprouting, electrical remodeling and the mechanisms of sudden cardiac death. Cardiovasc Res 2001; 50:409-416.
47. Cao JM, Fishbein MC, Han JB, et al. Relationship between regional cardiac hyperinnervation and ventricular arrhythmia. Circulation 2000; 101:1960-1969.
48. Tsai J, Cao JM, Zhou S, et al. T wave alternans as a predictor of spontaneous ventricular tachycardia in a canine model of sudden cardiac death. J Cardiovasc Electrophysiol 2002; 13:51-55.
49. Liu YB, Wu CC, Lu LS, et al. Sympathetic nerve sprouting, electrical remodeling, and increased vulnerability to ventricular fibrillation in hypercholesterolemic rabbits. Circ Res 2003; 92:1145-1152. Hypercholesterolemia provokes nerve sprouting, sympathetic hyperinnervation, and increased calcium current density. This remodeling is associated with increased vulnerability to ventricular fibrillation.
50. Antzelevitch C, Dumaine R. Electrical heterogeneity in the heart: physiological, pharmacological and clinical implications. In Handbook of Physiology. The Heart. Edited by Page E, Fozzard HA, Solaro RJ. New York: Oxford University Press; 2002:654-692.
51. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: a distinct clinical and electrocardiographic syndrome: a multicenter report. J Am Coll Cardiol 1992; 20:1391-1396.
52. Brugada R, Brugada J, Antzelevitch C, et al. Sodium channel blockers identify risk for sudden death in patients with ST-segment elevation and right bundle branch block but structurally normal hearts. Circulation 2000; 101:510-515.
53. Shimizu W, Antzelevitch C, Suyama K, et al. Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome. J Cardiovasc Electrophysiol 2000; 11:1320-1329.
54. Priori SG, Napolitano C, Gasparini M, et al. Clinical and genetic heterogeneity of right bundle branch block and ST-segment elevation syndrome: a prospective evaluation of 52 families. Circulation 2000; 102:2509-2515. [In Process Citation]
55. Brugada P, Brugada J, Brugada R. Arrhythmia induction by antiarrhythmic drugs. PACE 2000; 23:291-292.
56. Miyazaki T, Mitamura H, Miyoshi S, et al. Autonomic and antiarrhythmic drug modulation of ST segment elevation in patients with Brugada syndrome. J Am Coll Cardiol 1996; 27:1061-1070.
57. Babaliaros VC, Hurst JW. Tricyclic antidepressants and the Brugada syndrome: an example of Brugada waves appearing after the administration of desipramine. Clin Cardiol 2002; 25:395-398.
58. Goldgran-Toledano D, Sideris G, Kevorkian JP. Overdose of cyclic antidepressants and the Brugada syndrome. N Engl J Med 2002; 346:1591-1592.
59. Tada H, Sticherling C, Oral H, et al. Brugada syndrome mimicked by tricyclic antidepressant overdose. J Cardiovasc Electrophysiol 2001; 12:275.
60. Pastor A, Nunez A, Cantale C, et al. Asymptomatic Brugada syndrome case unmasked during dimenhydrinate infusion. J Cardiovasc Electrophysiol 2001; 12:1192-1194.
61. Ortega-Carnicer J, Bertos-Polo J, Gutierrez-Tirado C. Aborted sudden death, transient Brugada pattern, and wide QRS dysrhythmias after massive cocaine ingestion. J Electrocardiol 2001; 34:345-349.
62. Nogami A, Nakao M, Kubota S, et al. Enhancement of J-ST-segment elevation by the glucose and insulin test in Brugada syndrome. PACE 2003; 26:332-337.
63. Schwartz PJ. The idiopathic long QT syndrome: progress and questions. Am Heart J 1985; 109:399-411.
64. Moss AJ, Schwartz PJ, Crampton RS, et al. The long QT syndrome: prospective longitudinal study of 328 families. Circulation 1991; 84:1136-1144.
65. Zipes DP. The long QT interval syndrome: a Rosetta stone for sympathetic related ventricular tachyarrhythmias. Circulation 1991; 84:1414-1419.
66. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80:805-811.
67. Mohler PJ, Schott JJ, Gramolini AO, et al. Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. Nature 2003; 421:634-639.
68. Plaster NM, Tawil R, Tristani-Firouzi M, et al. Mutations in Kir2.1 cause the developmental and episodic electrical phenotypes of Andersen's syndrome. Cell 2001; 105:511-519.
69. Curran ME, Splawski I, Timothy KW, et al. A molecular basis for cardiac arrhythmia: HERG mutations cause long QT syndrome. Cell 1995; 80:795-803.
70. Wang Q, Curran ME, Splawski I, et al. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat Genet 1996; 12:17-23.
71. Ks function. Nat Genet 1998; 17:338-340.
72. Bednar MM, Harrigan EP, Anziano RJ, et al. The QT interval. Prog Cardiovasc Dis 2001; 43:1-45.
73. Tomaselli GF, Marban E. Electrophysiological remodeling in hypertrophy and heart failure. Cardiovasc Res 1999; 42:270-283.
74. Sipido KR, Volders PG, De Groot SH, et al. Enhanced Ca(2+) release and Na/Ca exchange activity in hypertrophied canine ventricular myocytes: potential link between contractile adaptation and arrhythmogenesis. Circulation 2000; 102:2137-2144.
75. Volders PG, Sipido KR, Vos MA, et al. Downregulation of delayed rectifier K(+) currents in dogs with chronic complete atrioventricular block and acquired torsades de pointes. Circulation 1999; 100:2455-2461.
76. Undrovinas AI, Maltsev VA, Sabbah HN. Repolarization abnormalities in cardiomyocytes of dogs with chronic heart failure: role of sustained inward current. Cell Mol Life Sci 1999; 55:494-505.
77. Maltsev VA, Sabbah HN, Higgins RS, et al. Novel, ultraslow inactivating sodium current in human ventricular cardiomyocytes. Circulation 1998; 98:2545-2552.
78. Antzelevitch C, Shimizu W. Cellular mechanisms underlying the long QT syndrome. Curr Opin Cardiol 2002; 17:43-51.
79. Belardinelli L, Antzelevitch C, Vos M. Potential predictors of drug-induced Torsade de Pointes: early afterdepolarizations, ectopic beats and increased dispersion of ventricular repolarization. TIPS 2003; in press.
80. Shimizu W, Antzelevitch C. Effects of a K(+) channel opener to reduce transmural dispersion of repolarization and prevent Torsade de Pointes in LQT1, LQT2, and LQT3 models of the long-QT syndrome. Circulation 2000; 102:706-712.
81. Schwartz PJ, Priori SG, Spazzolini C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation 2001; 103:89-95. [In Process Citation]
82. Shimizu W, Antzelevitch C. Cellular basis for the electrocardiographic features of the LQT1 form of the long QT syndrome: effects of β-adrenergic agonists, antagonists and sodium channel blockers on transmural dispersion of repolarization and Torsade de Pointes. Circulation 1998; 98:2314-2322.
83. Ali RH, Zareba W, Moss A, et al. Clinical and genetic variables associated with acute arousal and nonarousal-related cardiac events among subjects with long QT syndrome. Am J Cardiol 2000; 85:457-461.
84. Shimizu W, Antzelevitch C. Sodium channel block with mexiletine is effective in reducing dispersion of repolarization and preventing Torsade de Pointes in LQT2 and LQT3 models of the long-QT syndrome. Circulation 1998; 96:2038-2047.
85. Shimizu W, Antzelevitch C. Differential effects of beta-adrenergic agonists and antagonists in LQT1, LQT2 and LQT3 models of the long QT syndrome. J Am Coll Cardiol 2000; 35:778-786.
86. Noda T, Takaki H, Kurita T, et al. Gene-specific response of dynamic ventricular repolarization to sympathetic stimulation in LQT1, LQT2 and forms of congenital long QT syndrome. Eur Heart J 2002; 23:975-983.
87. Antzelevitch C. Sympathetic modulation of the long QT syndrome. Eur Heart J 2002; 23:1246.
88. Windle JR, Geletka RC, Moss AJ, et al. Normalization of ventricular repolarization with flecainide in long QT syndrome patients with SCN5A:DeltaKPQ mutation. Ann Noninvasive Electrocardiol 2001; 6:153-158.
89. Roden DM. Pharmacogenetics and drug-induced arrhythmias. Cardiovasc Res 2001; 50:224-231.
90. Lampert R, Joska T, Burg MM, et al. Emotional and physical precipitants of ventricular arrhythmia. Circulation 2002; 106:1800-1805. Anger and physical activity can trigger ventricular arrhythmias in patients with ICDs.
91. Fries R, Konig J, Schafers HJ, et al. Triggering effect of physical and mental stress on spontaneous ventricular tachyarrhythmias in patients with implantable cardioverter-defibrillators. Clin Cardiol 2002; 25:474-478. Physical activity (based on sweating or dyspnea) and mental stress (tension/nervousness, depression, or anger) significantly increase risk of ICD shocks.
92. Kovach JA, Nearing BD, Verrier RL. Angerlike behavioral state potentiates myocardial ischemia-induced T-wave alternans in canines. J Am Coll Cardiol 2001; 37:1719-1725.
93. Kop WJ, Nearing BD, Krantz DS, et al. Increased T-wave alternans with mental stress and exercise in implantable cardioverter defibrillator patients. Circulation 100, I-581. 1999.
94. Mittleman MA, Maclure M, Sherwood JB, et al. Triggering of acute myocardial infarction onset by episodes of anger. Determinants of Myocardial infarction Onset Study Investigators. Circulation 1995; 92:1720-1725.
95. Verrier RL, Nearing BD, La Rovere MT, et al. Ambulatory electrocardiogram-based tracking of T wave alternans in postmyocardial infarction patients to assess risk of cardiac arrest or arrhythmic death. J Cardiovasc Electrophysiol 2003; 14:705-711. The first study of TWA on 24-hour AECG provided evidence that post-myocardial infarction patients with TWA values above ∼50 μV during peak heart rate or at 8:00 AM were at four- to sevenfold greater risk of cardiac arrest or arrhythmic death than those with lower TWA values at these time points.
96. Klingenheben T, Gronefeld G, Li YG, et al. Effect of metoprolol and d,l-sotalol on microvolt-level T-wave alternans: results of a prospective, double-blind, randomized study. J Am Coll Cardiol 2001; 38:2013-2019.
97. Rashba EJ, Cooklin M, MacMurdy K, et al. Effects of selective autonomic blockade on T-wave alternans in humans. Circulation 2002; 105:837-842.
98. Verrier RL, Mittleman MA. Sleep-related cardiac risk. In Principles and Practice of Sleep Medicine. Edited by Kryer MH, Roth T, Dement WC. Philadelphia: WB Saunders; 2000: 997-1013.
99. Lanfranchi PA, Somers VK, Braghiroli A, et al. Central sleep apnea in left ventricular dysfunction: prevalence and implications for arrhythmic risk. Circulation 2003; 107:727-732. Central sleep apnea is prevalent in patients with asymptomatic left ventricular dysfunction. Apnea severity is associated with impaired cardiac autonomic control and increased cardiac arrhythmias.